36C24524Q0636_1.docx

36C24524Q0636

GENERAL INFORMATION

SET-ASIDE

VA Maryland Health Care System Contracting Officer (90C) P.O. Box 1000, Bldg. 101, Room 26 Perry Point MD 21902

POINT OF CONTACT*

Contracting Officer Kami Hom Kami.Hom@va.gov

PLACE OF PERFORMANCE

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

DESCRIPTION

See RFQ below.

Fill out and return attached Line items template with your response.

All Questions are due in writing to Kami.Hom@va.gov by July 1, 2024 no later than 4:30pm est.

All Responses are due in writing to Kami.Hom@va.gov by July 10, 2024 no later than 09:00am est.

Combined Synopsis/Solicitation Notice Combined Synopsis/Solicitation Notice

Combined Synopsis/Solicitation Notice

PAGE 1 OF

1. REQUISITION NO.

2. CONTRACT NO.

3. AWARD/EFFECTIVE DATE

4. ORDER NO.

5. SOLICITATION NUMBER

6. SOLICITATION ISSUE DATE

a. NAME

b. TELEPHONE NO. (No Collect Calls)

8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY

CODE

10. THIS ACQUISITION IS

UNRESTRICTED OR

SET ASIDE:

% FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL

BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b.

RATING

14. METHOD OF SOLICITATION

RFQ

IFB

RFP

15. DELIVER TO

CODE

16. ADMINISTERED BY

CODE

17a. CONTRACTOR/OFFEROR

CODE

FACILITY CODE

18a. PAYMENT WILL BE MADE BY

CODE

TELEPHONE NO.

UEI:

EFT:

PHONE:

FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER 18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19.

20.

21.

22.

23.

24.

ITEM NO.

SCHEDULE OF

SUPPLIES/SERVICES

QUANTITY

UNIT

UNIT PRICE

AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA

26. TOTAL AWARD AMOUNT (For Govt. Use Only) 27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA

ARE

ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA

ARE

ARE NOT

ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________

29. AWARD OF CONTRACT: REF. ___________________________________ OFFER

COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND

DATED ________________________________. YOUR OFFER ON SOLICITATION

DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY

(BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE

ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIO

NS SPECIFIED

SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER) 30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTR

ACTING OFFICER (TYPE OR PRINT)

31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION

(REV. NOV 2021)

PREVIOUS EDITION IS NOT USABLE

Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

36C24524Q0636 Kami Hom 410-642-2411 x22404 07-10-2024 9:00am

EDT

Department of Veterans Affairs VA Maryland Health Care System Contracting Officer (90C) P.O. Box 1000, Bldg. 101, Room 26 Perry Point MD 21902 X 325412 1300 Employees N/A X Department of Veterans Affairs VA Maryland Health Care System 10 North Greene Street Baltimore MD 21201 Department of Veterans Affairs VA Maryland Health Care System Contracting Officer (90C) P.O. Box 1000, Bldg. 101C Room 3 Perry Point MD 21902

PAYMENT WILL BE MADE BY

FSC e-Invoice Payment Invoice must be submitted electronically http://www.fsc.va.gov/einvoice.asp Invoice Setup Information 1-877-489-6135 See CONTINUATION Page Radio-Pharmaceutical Isotopes for Nuclear Medicine Period of Performance 10/01/2024 - 09/30/2029 Please see pages 4-for detailed information.

All Questions are due in writting to Kami.Hom@va.gov by July 1, 2024 no later then 4:30pm est.

All Responses are due in writting to Kami.Hom@va.gov by July 10, 2024 no later then 9:00m est.

See CONTINUATION Page X X Kami Hom Contracting Officer Page 1 of Table of Contents

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1. Contract Administration: All contract administration matters will be handled by the following individuals:

b. GOVERNMENT: Department of Veterans Affairs VA Maryland Health Care System Kami Hom, Contracting Officer (90C) P.O. Box 1000, Bldg. 101-C, Room 8 Perry Point MD 21902 410-642-2411 x22404 Kami.Hom@va.gov

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

3. INVOICES: Invoices shall be submitted in arrears:

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.

http://www.fsc.va.gov/einvoice.asp

ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:

B.2 STATEMENT OF WORK

Statement of Work Blanket Purchase Agreement (BPA) for Medical Isotope Supply for Baltimore VA Medical Center

1. Overview This Blanket Purchase Agreement (BPA) establishes a relationship between the Baltimore VA Medical Center located at 10 North Greene Street, Baltimore, MD 21201 (hereinafter referred to as "BT VAMC") and the contractor, for the supply of Radiopharmaceutical products and delivery services. The contractor shall provide all items as listed in the Supplies and Service Schedule of this contract. It is the intent of the BT VAMC to make a single award for this Radiopharmaceuticals be furnished on a daily, as needed basis, as determined by the Nuclear Medicine and PET departments. Miland Valencia acts as the authorized representative for the BT VAMC in this BPA.

2. Regulatory Compliance The Contractor shall ensure full compliance with all applicable federal, state, and local laws, regulations, and guidelines pertaining to the manufacturing, handling, storage, transportation, and disposal of radiopharmaceuticals, including but not limited to the following:

A. Nuclear Regulatory Commission (NRC): Adherence to all NRC regulations concerning the use, storage, handling, and disposal of radioactive materials. This includes maintaining valid licenses for the possession and distribution of radiopharmaceuticals and ensuring that all personnel involved in the handling of these materials are properly trained and licensed.

B. Food and Drug Administration (FDA): Compliance with FDA regulations for the approval, production, labeling, and distribution of radiopharmaceuticals. This includes adherence to Current Good Manufacturing Practices (cGMPs) as outlined in 21 CFR Parts 210 and 211, and meeting requirements for drug efficacy and safety reporting.

C. Department of Transportation (DOT): Compliance with DOT regulations for the safe and secure transportation of hazardous materials, as outlined in 49 CFR Parts 100-185. The Contractor must ensure that all shipments of radiopharmaceuticals are properly classified, packaged, marked, labeled, and accompanied by the appropriate shipping documentation.

D. The Contractor must maintain all records of compliance and make them available for review upon request by the Baltimore VA Medical Center or any regulatory body. In the event of any changes in applicable laws or regulations, the Contractor is required to promptly adjust its operations to maintain compliance and notify the Baltimore VA Medical Center of any such changes that may affect the provision of services under this agreement.

The Contractor's failure to comply with any of the above regulatory requirements may result in immediate termination of this contract, at the discretion of the Baltimore VA Medical Center, in addition to any other remedies available under law.

3. Product Supply and Availability The Contractor is responsible for the consistent, reliable supply of high-quality radiopharmaceuticals to the Baltimore VA Medical Center. This responsibility encompasses the following detailed provisions:

A. Product Range: The Contractor shall provide a comprehensive list of radiopharmaceuticals available under this BPA, including but not limited to, those required for diagnostic imaging, therapy, and research purposes. This list should be updated periodically to reflect any new products or changes in availability.

B. Supply Reliability: The Contractor guarantees a reliability rate of 98% for the timely delivery of ordered radiopharmaceuticals. This rate is calculated as the percentage of on-time deliveries out of the total deliveries within a specified period.

C. Order Fulfillment: The Contractor commits to fulfilling orders placed by the Baltimore VA Medical Center within the agreed-upon delivery windows. For products in high demand or with short half-lives, the Contractor shall prioritize order processing and utilize expedited shipping methods when necessary to meet delivery timelines.

D. Quality Assurance: All supplied radiopharmaceuticals must meet or exceed the quality standards specified by the Food and Drug Administration (FDA) and relevant industry standards. The Contractor is responsible for ensuring that each product batch is accompanied by a Certificate of Analysis (CoA) verifying its identity, strength, purity, and quality.

E. Emergency Supply: In the event of urgent or unexpected needs, the Contractor shall have a procedure in place for emergency orders. This includes the ability to expedite processing and delivery of radiopharmaceuticals to address critical shortages or immediate patient care needs.

F. Backorder Management: Should any product become temporarily unavailable (backordered), the Contractor must immediately notify the Baltimore VA Medical Center, providing an estimated availability date and suggesting equivalent alternative products if available. The Contractor shall take all reasonable steps to resolve backorders and resume supply as quickly as possible.

G. Reporting and Communication: Regular communication channels shall be maintained to ensure the Baltimore VA Medical Center is informed of any developments affecting product supply and availability.

Failure to adhere to these supply and availability requirements may result in penalties, including but not limited to financial compensation for the Baltimore VA Medical Center, and may impact the Contractor's eligibility for contract renewal.

4. Labeling and Packaging The Contractor is required to adhere to strict labeling and packaging standards for all radiopharmaceuticals supplied under this BPA, ensuring compliance with federal, state, and local regulations, and promoting the safe handling and use of these materials. The requirements include:

A. Labeling: Each product must be labeled clearly and legibly with all necessary information, including but not limited to:

- The name of the radiopharmaceutical.

- The radionuclide and its activity in Becquerels or Curies, including the calibration time.

- Expiry date/time.

- Lot or batch number.

- Manufacturer's name and address.

- Appropriate radiation symbols and warnings.

- Any specific handling instructions.

The label must also include a barcode or QR code that links to a digital copy of the detailed product information and handling instruction.

B. Packaging: Packaging must ensure the integrity and safety of the radiopharmaceuticals during transportation and storage. This includes:

I. Use of lead or equivalent shielding containers for radioactive materials to ensure exposure levels are as low as reasonably achievable (ALARA).

II. Secondary containment to prevent leakage or contamination in the event of primary container failure.

III. Packaging materials that are compatible with the radiopharmaceuticals to avoid chemical degradation or reactions.

IV. Tamper-evident features to indicate if the product has been opened or altered after leaving the manufacturing facility.

C. Transportation Packaging: In addition to the above, packaging for transportation must comply with Department of Transportation (DOT) regulations for hazardous materials. This includes:

I. Proper classification, marking, and labeling of packages as per DOT requirements.

II. Use of UN-approved shipping containers for radioactive materials.

III. Inclusion of all necessary shipping papers, emergency response information, and declarations for dangerous goods.

D. Documentation: Each shipment must be accompanied by documentation that includes the product's name, quantity, lot number, expiration date, and a Certificate of Analysis (CoA). Safety data sheets (SDS) for each radiopharmaceutical must also be provided, detailing hazards, handling precautions, and first-aid measures upon request.

E. Custom Labeling and Packaging: Upon request, the Contractor must be able to provide custom labeling and packaging solutions to meet specific needs of the Baltimore VA Medical Center, such as unit-dose packaging or patient-specific labeling.

Failure to comply with these labeling and packaging requirements may result in the rejection of delivered products, financial penalties, and/or termination of the contract. The Contractor is responsible for any costs associated with the return, replacement, or disposal of non-compliant products.

6. Returns and Credits The contractor shall accept returns for credit under specific conditions, such as errors in order or shipment, damaged products, recalled products, and outdated products in unopened, original containers. A clear return policy and process for invoice adjustments will be communicated to the BT VAMC.

7. Invoicing The Contractor shall submit certified invoices on a monthly basis, detailing all transactions within the billing period, including product names, quantities, amounts, and any credits for returns.

8. Ordering Process Post-award, the contractor will be provided with the names of individuals authorized by the Baltimore VA Medical Center to place orders against this BPA. The Contracting Officer Representative (COR), designated by the medical center, will oversee the administration and compliance with the BPA terms.

9. Specifications and Schedule Specifications for the radiopharmaceutical products and the delivery schedule will be based on the as-needed requests by the Nuclear Medicine and PET departments of the Baltimore VA Medical Center. The contractor is required to provide service through normal business hours and on call after hours 24/7 coverage if requested and comply with delivery and quality control specifications as detailed. Unit dose containers shall be picked up daily. Contractor to supply and deliver twice a day on normal working days, with the first delivery by 7:00 am eastern standard time. Emergency deliveries shall be received within (1) or (2) hours of request. Daily “call-in” or “on-line” orders by authorized person(s) or doses required by following morning. Confirmation of orders is reviewed and received.

--June 19th Emancipation Day

--any other day specifically declared by the President of the United States to be a national holiday.

10. Duration This BPA is effective from date of award for five (5) years, subject to the terms and conditions herein.

11. Provision for Product List Updates and New Product Additions The Contractor acknowledges the importance of providing the most current and effective radiopharmaceuticals to meet the evolving needs of the Baltimore VA Medical Center. Therefore, it is agreed as follows:

1. Product List: The Contractor shall maintain an up-to-date list of all radiopharmaceuticals available under this Blanket Purchase Agreement (BPA). This list will include detailed information on each product, including specifications, intended use, and regulatory compliance status. The Contractor commits to providing the Baltimore VA Medical Center with updates to this product list at a minimum on a quarterly basis, or more frequently as new products become available or existing products are discontinued. Below is the current product list anticipated for order.

Code

Sincalide Vial

Tc-99m Bicisate UD

Tc-99m NaTcO4 MD (per mCi) mCi

Tc-99m NaTcO4 UD mCi (up to 30 mCi) mCi

Tc-99m Exametazime WBC's

Tl-201 Thallous Chloride UD (per mCi)

Xe-133 Xenon Gas 20 mCi Vial

Xe-133 Xenon Gas 10 mCi Vial

Tc-99m Cardiolite UD (up to 30 mCi)

After Hours Callout

After Hours Delivery Charge

Stat

24 hours

Weekday Delivery 1

Per day

Weekday Delivery 2

Per day

Weekday Delivery 3

Per day

Weekday Delivery 4

Per day

Weekday Delivery 5

Per day

Weekend Delivery 1

Per day

Weekend Delivery 2

Per day

Weekend Delivery 3

Per day

2. New Product Additions: Throughout the duration of this contract, the Contractor may introduce new radiopharmaceuticals to the market. Any new product that is added to the BPA or additional changes required throughout the life of the BPA, will be done via a modification signed by the Contracting Officer. Changes that occur to the BPA without the approval of the Contracting Officer may result in an unauthorized commitment.

3. Order Eligibility: The Vendor will make every effort to inform the Baltimore VA Medical Center when new radio-pharmaceutical drugs supplied will become available. This ensures the Baltimore VA is informed to the latest advancement in radiopharmaceuticals and can adapt its treatment options if necessary.

12. Certificate Submission Requirement with Quote In order to maintain the highest standards of quality and compliance with regulatory requirements, all offerors are hereby required to submit the following certificates along with their quotes:

1. Certificate of Good Manufacturing Practices (GMP) Compliance: This certificate should be current and valid, indicating that the manufacturing facilities used to produce the radiopharmaceuticals comply with the Good Manufacturing Practices as stipulated by relevant health and safety regulatory bodies.

2. Quality Assurance Certificates: These certificates should verify that the radiopharmaceutical products meet the specified quality criteria and are safe for use. They should include any test reports and quality control measures undertaken.

3. Regulatory Compliance Certificates: These should demonstrate compliance with all relevant local, state, and federal regulations pertaining to the production, handling, and distribution of radiopharmaceuticals. This includes, but is not limited to, licenses and approvals from health and regulatory authorities.

By agreeing to these provisions, both parties affirm their commitment to a dynamic and responsive partnership that prioritizes patient care and embraces the ongoing advancements in radiopharmaceutical technology.

13. Delivery tickets.

A requirement that all shipments under the agreement, except those for newspapers, magazines, or other periodicals, shall be accompanied by delivery tickets or sales slips that shall contain the following minimum information:

(i) Name of supplier.

(ii) BPA number.

(iii) Date of purchase.

(iv) Purchase number.

(v) Itemized list of supplies or services furnished.

(vi) Quantity, unit price, and extension of each item, less applicable discounts (unit prices and extensions need not be shown when incompatible with the use of automated systems, provided that the invoice is itemized to show this information).

(vii) Date of delivery or shipment.

14. Points of Contact

- CO (Contracting Officer): Kami Hom

- COR (Contracting Officer's Representative): Miland Valencia

- Contractor Designee: [Contractor representative's name]

B.3 INTRODUCTION

The agreement details all supplies with accompanying prices and descriptions, which may be ordered under this BPA.

This BPA expires on 9/30/2029 or such later ending date as determined by the exercise of any option.

All orders placed against this BPA are subject to the terms and conditions of all the clauses and provisions in full text or incorporated by reference in this document.

B.4 AUTHORIZED LIMITS

The Government estimates, but does not guarantee, that individual BPA Orders placed against this Agreement may reach $250,000.00 per Order. This Order Limit may be increased by mutual agreement of the parties as necessary, in whole or part. The authorized Ceiling Limit of the Agreement is set at $4,000,000.00 over the period covered by the Agreement; this ceiling is also not a guarantee. The Ceiling Limit may also be raised in association with order Limit increases or other conditions which, by mutual agreement of the parties, maybe considered necessary. Authorization for individual Task Orders above the stated Task Order and/or Ceiling Limits must be coordinated through the Contracting Officer before larger valued orders can be issued and prior to commencement of work. All unauthorized work, regardless of amount, will be processed through the ratification process.

B.5 OBLIGATION OF FUNDS

This BPA does not obligate any funds. The Government is obligated only to the extent of authorized orders actually issued under the BPA by the Contracting Officer, placement of orders is not guaranteed.

B.6 PERIOD OF PERFORMANCE

This BPA expires on 9/30/2029 or such later ending date as determined by the exercise of any option.

B.7 ORDER FORMAT

Orders will be placed against this BPA via e-mail, Electronic Data Interchange (EDI), FAX, or in hardcopy format. Each individual BPA Task Order will describe the tasks, services and deliverables required.

B.8 EXTENT OF OBLIGATION

The Government is obligated only to the extent of authorized purchases actually made under the BPA.

B.9 PRICE/COST SCHEDULE

ITEM INFORMATION

Daily formulation and delivery of Neulear Isotopes products for patient care in Nuclear Medicine and PET/CT for the period of 10/1/2024 – 9/30/2025 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

0001AA

F-18 FDG UD

NDC Code: 40028-511-30 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102192

NATIONAL STOCK NUMBER: 102192

LOCAL STOCK NUMBER: 102192

0001AB

F-18 FDG UD Source

Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102193

NATIONAL STOCK NUMBER: 102193

LOCAL STOCK NUMBER: 102193

0001AC

F-18 NaF UD NDC Code: 49609-102-01 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102204

NATIONAL STOCK NUMBER: 102204

LOCAL STOCK NUMBER: 102204

0001AD

Ga-67 Gallium Citrate UD (per mCi) NDC Code: 69945-180-12 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102279

NATIONAL STOCK NUMBER: 102279

LOCAL STOCK NUMBER: 102279

0001AE

I-131 USP NaI DX Cap mCi NDC Code: 69208-000-00 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102366

NATIONAL STOCK NUMBER: 102366

LOCAL STOCK NUMBER: 102366

0001AF

I-131 USP NaI DX Cap uCi (per cap)

Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102367

NATIONAL STOCK NUMBER: 102367

LOCAL STOCK NUMBER: 102367

0001AG

I-131 USP NaI TX Cap (up to 6 mCi)

Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102372

NATIONAL STOCK NUMBER: 102372

LOCAL STOCK NUMBER: 102372

0001AH

I-131 USP NaI TX Cap (each addl mCi)

Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102372

0001AI

In-111 Pentetreotide UD

Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102400

NATIONAL STOCK NUMBER: 102400

LOCAL STOCK NUMBER: 102400

0001AJ

In-111 WBC Bld Kit (Heparin&Hetastarch) NDC Code: 69945-050-40 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102408

NATIONAL STOCK NUMBER: 102408

LOCAL STOCK NUMBER: 102408

0001AK

In-111 WBC Blood Kit (Heparin)

Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102409

NATIONAL STOCK NUMBER: 102409

LOCAL STOCK NUMBER: 102409

0001AL

In-111 Autologous WBC Suspension

Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102410

NATIONAL STOCK NUMBER: 102410

LOCAL STOCK NUMBER: 102410

0001AM

Pyrophosphate Vial NDC Code: 69945-094-20 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102684

NATIONAL STOCK NUMBER: 102684

LOCAL STOCK NUMBER: 102684

0001AN

Sincalide Vial NDC Code: 0270-0556-15 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102767

NATIONAL STOCK NUMBER: 102767

LOCAL STOCK NUMBER: 102767

0001AO

Tc-99m Bicisate UD NDC Code: 11994-006-05 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102932

NATIONAL STOCK NUMBER: 102932

LOCAL STOCK NUMBER: 102932

0001AP

Tc-99m Filtered Sulfur Colloid UD NDC Code: 45567-0030-1 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102943

NATIONAL STOCK NUMBER: 102943

LOCAL STOCK NUMBER: 102943

0001AQ

Tc-99m Macro Aggregated Albumin UD NDC Code: 65174-270-30 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102970

NATIONAL STOCK NUMBER: 102970

LOCAL STOCK NUMBER: 102970

0001AR

Tc-99m Mebrofenin UD NDC Code: 45567-0455-1 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102974

NATIONAL STOCK NUMBER: 102974

LOCAL STOCK NUMBER: 102974

0001AS

Tc-99m Medronate UD NDC Code: 65174-660-30 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102977

NATIONAL STOCK NUMBER: 102977

LOCAL STOCK NUMBER: 102977

0001AT

Tc-99m Mertiatide UD NDC Code: 69945-096-20 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102980

NATIONAL STOCK NUMBER: 102980

LOCAL STOCK NUMBER: 102980

0001AU

Tc-99m NaTcO4 MD (per mCi) NDC Code: N/A Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102983

NATIONAL STOCK NUMBER: 102983

LOCAL STOCK NUMBER: 102983

0001AV

Tc-99m NaTcO4 UD mCi (up to 30 mCi)

Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102984

NATIONAL STOCK NUMBER: 102984

LOCAL STOCK NUMBER: 102984

0001AW

Tc-99m Pyrophosphate UD

Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102991

NATIONAL STOCK NUMBER: 102991

LOCAL STOCK NUMBER: 102991

0001AX

Tc-99m Sestamibi UD (up to 30 mCi) NDC Code: 69445-092-40 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102994

NATIONAL STOCK NUMBER: 102994

LOCAL STOCK NUMBER: 102994

0001AY

Tc-99m Sulfur Colloid UD

Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103003

NATIONAL STOCK NUMBER: 103003

LOCAL STOCK NUMBER: 103003

0001AZ

Tc-99m Tetrofosmin UD (up to 30 mCi) NDC Code: 69945-092-40 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103006

NATIONAL STOCK NUMBER: 103006

LOCAL STOCK NUMBER: 103006

0001BA

Tc-99m WBC Blood Kit (Heparin) NDC Code: 69945-068-20 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103011

NATIONAL STOCK NUMBER: 103011

LOCAL STOCK NUMBER: 103011

0001BB

Tc-99m Exametazime WBC's

Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103012

NATIONAL STOCK NUMBER: 103012

LOCAL STOCK NUMBER: 103012

0001BC

Tl-201 Thallous Chloride UD (per mCi) NDC Code: 69945-120-20 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103039

NATIONAL STOCK NUMBER: 103039

LOCAL STOCK NUMBER: 103039

0001BD

UltraTag Vial NDC Code: 69445-068-20 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103080

NATIONAL STOCK NUMBER: 103080

LOCAL STOCK NUMBER: 103080

0001BE

Xe-133 Xenon Gas 20 mCi Vial NDC Code: 69945-092-23 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103099

NATIONAL STOCK NUMBER: 103099

LOCAL STOCK NUMBER: 103099

0001BF

Xe-133 Xenon Gas 10 mCi Vial

Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103099

0001BG

Tc-99m Cardiolite UD (up to 30 mCi) NDC Code: 11994-001-20 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103099

0001BH

Tc-99m Filtered Sulfur Colloid (uCi) UD

Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103099

0001BI

Tc-99m Sulfur Colloid Egg Substitute

Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103099

0001BJ

Cu-64 Dotatate NDC Code: 69945-064-01 Contract Period: Base POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 107858

NATIONAL STOCK NUMBER: 107858

LOCAL STOCK NUMBER: 107858

0001BK

After Hours Callout

POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): N/A

NATIONAL STOCK NUMBER: N/A

LOCAL STOCK NUMBER: N/A

0001BL

After Hours Delivery Charge

POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): N/A

0001BM

Stat

POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): N/A

0001BN

Weekday Delivery 1

POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): N/A

0001BO

Weekday Delivery 2

POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): N/A

0001BP

Weekday Delivery 3

POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): N/A

0001BQ

Weekday Delivery 4

POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): N/A

0001BR

Weekday Delivery 5

POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): N/A

0001BS

Weekend Delivery 1

POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): N/A

0001BT

Weekend Delivery 2

POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): N/A

0001BU

Weekend Delivery 3

POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): N/A

Daily formulation and delivery of Neulear Isotopes products for patient care in Nuclear Medicine and PET/CT for the period of 10/1/2025 – 9/30/2026

POP Begin: 10-01-2025 POP End: 09-30-2026

0002AA

F-18 FDG UD

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102192

0002AB

F-18 FDG UD Source

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102193

0002AC

F-18 NaF UD

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102204

0002AD

Ga-67 Gallium Citrate UD (per mCi)

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102279

0002AE

I-131 USP NaI DX Cap mCi

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102366

0002AF

I-131 USP NaI DX Cap uCi (per cap)

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102367

0002AG

I-131 USP NaI TX Cap (up to 6 mCi)

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102372

0002AH

I-131 USP NaI TX Cap (each addl mCi)

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102372

0002AI

In-111 Pentetreotide UD

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102400

0002AJ

In-111 WBC Bld Kit (Heparin&Hetastarch)

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102408

0002AK

In-111 WBC Blood Kit (Heparin)

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102409

0002AL

In-111 Autologous WBC Suspension

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102410

0002AM

Pyrophosphate Vial

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102684

0002AN

Sincalide Vial

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102767

0002AO

Tc-99m Bicisate UD

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102932

0002AP

Tc-99m Filtered Sulfur Colloid UD

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102943

0002AQ

Tc-99m Macro Aggregated Albumin UD

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102970

0002AR

Tc-99m Mebrofenin UD

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102974

0002AS

Tc-99m Medronate UD

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102977

0002AT

Tc-99m Mertiatide UD

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102980

0002AU

Tc-99m NaTcO4 MD (per mCi)

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102983

0002AV

Tc-99m NaTcO4 UD mCi (up to 30 mCi)

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102984

0002AW

Tc-99m Pyrophosphate UD

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102991

0002AX

Tc-99m Sestamibi UD (up to 30 mCi)

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102994

0002AY

Tc-99m Sulfur Colloid UD

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103003

0002AZ

Tc-99m Tetrofosmin UD (up to 30 mCi)

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103006

0002BA

Tc-99m WBC Blood Kit (Heparin)

Contract Period: Base POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN):…